Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has disclosed the schedule of two upcoming investor meetings as required under SEBI LODR Regulation 30. On June 1, 2026, the company will hold a one-on-one meeting with Carnelian Asset Management. On June 8, 2026, it will participate in the ICICI Securities India Investor Conference 2026, holding both one-on-one and group meetings. The company notes that the schedule is subject to change due to exigencies on either side. This is a routine disclosure with no new strategic or financial information provided.
No material impact on the stock. This is a standard compliance filing indicating the company is in active dialogue with institutional investors, which is routine for listed companies.